News & Updates

Blood-based biomarkers (BBBs) may potentially aid earlier detection of Alzheimer’s disease (AD) following a recent revision of diagnostic criteria supporting core biomarker–based diagnosis. Initial local experience with lecanemab, a disease-modifying therapy (DMT) for patients with mild cognitive impairment or mild dementia due to AD, was shared at Advances in Medicine (AIM) 2025.

Hospital isolation for COVID-19 caused heightened anxiety in families, particularly children, during the early phase of the pandemic, according to a Singapore study.

Adverse childhood experiences (ACEs), such as abuse, neglect, and household dysfunction, appear to contribute to the development of obesity during adulthood, suggests an Iraq study presented at ESPGHAN 2025.